MarketBeat cites USD 102.05 target for Rocket Lab stock

Published on 10/27/2026 at 20:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue in the second quarter was USD 234.07 million. Rocket Lab stock costs EUR 52.15 on October 27, 2026, up 8.36 percent on Nasdaq.

Analyst target and reporting date

MarketBeat reported a USD 102.05 consensus target for Rocket Lab on October 18, 2026.
Rocket Lab revenue reached USD 234.07 million in the second quarter of fiscal 2026.
Rocket Lab stock costs EUR 52.15 at Lang & Schwarz on October 27, 2026 at 8:03 p.m. CET, up 8.36 percent versus the Nasdaq prior close.
Rocket Lab's third-quarter 2026 results are scheduled for November 9, 2026.

Rocket Lab, US7731211089, Illustration mit AI erstellt.

Rocket Lab (ISIN US7731211089) carries a USD 102.05 average 12-month price target from 23 analysts, according to MarketBeat on October 18, 2026. Rocket Lab was trading at EUR 52.15 at Lang & Schwarz on October 27, 2026 at 8:03 p.m. CET, up 8.36 percent versus the Nasdaq prior close of October 26, 2026.

Consensus target stays above Nasdaq quote

The consensus included 14 buy ratings, three strong-buy ratings, five holds and one sell rating, with USD 102.05 as the average target. The target stands 75.11 percent above the latest Nasdaq price of USD 58.31, calculated from the same-currency figures.

Investing.com reported on October 26, 2026 that Cantor Fitzgerald reiterated an Overweight rating and a USD 122.00 target. That target is 109.23 percent above USD 58.31, outside the distance range used for the consensus comparison.

Revenue growth meets a wider cash need

Rocket Lab revenue reached USD 234.07 million in the second quarter of fiscal 2026, up 62.00 percent from the prior-year quarter, according to Trefis on October 21, 2026. The operating loss was 29.10 percent of revenue over the four quarters through June 30, 2026, compared with 44.10 percent one year earlier.

The same review put Rocket Lab's backlog at USD 2.36 billion at the end of June and cash plus short-term investments at USD 2.30 billion, against USD 134.00 million of debt. The figures frame the central investor tradeoff: revenue is expanding, while development spending keeps the path to profitability open-ended.

Price position and reporting date

Rocket Lab's Nasdaq quote was USD 58.31 at 3:05 p.m. ET on October 27, 2026, versus USD 53.82 at the prior close. Its 52-week range was USD 37.57 to USD 151.00, leaving the latest price 61.38 percent below the high and 55.22 percent above the low. Market capitalization stood at USD 34.9 billion.

Rocket Lab's third-quarter 2026 financial results are scheduled for November 9, 2026, at 5:00 p.m. ET, according to the company's investor-relations calendar at Rocket Lab. The date gives the next report a clear test: whether quarterly revenue can enter the company's stated USD 250.00 million to USD 265.00 million outlook.

Comparison with peers

Rocket Lab: up 8.36 percent, negative P/E of -210.62, market capitalization USD 34.9 billion.

Lockheed Martin (NYSE, USD): down 1.44 percent, P/E 22.23, market capitalization USD 144.6 billion.

Northrop Grumman (NYSE, USD): down 2.12 percent, P/E 17.43, market capitalization USD 78.6 billion.

Rocket Lab stock keeps the focus on execution

The current valuation gives the analyst consensus room for error, but the second-quarter revenue gain and the USD 2.36 billion backlog provide concrete operating support. The November 9 report will put that support against the next revenue figure.

The further course of trading is shown by the continuously updated real-time quote of Rocket Lab stock.